North Star Asset Management’s Array Biopharma Inc ARRY Stock Holding History

North Star Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-37,600	Closed	-$1.74M	–	290
2019 Q2	$1.74M	Hold	37,600	–	–	0.14%	125
2019 Q1	$917K	Hold	37,600	–	–	0.07%	153
2018 Q4	$536K	Hold	37,600	–	–	0.05%	186
2018 Q3	$572K	Hold	37,600	–	–	0.05%	198
2018 Q2	$631K	Hold	37,600	–	–	0.05%	183
2018 Q1	$614K	Hold	37,600	–	–	0.06%	183
2017 Q4	$481K	Buy	+37,600	New	+$428K	0.04%	203

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

North Star Asset Management's ARRY Position: Q3 2019 in Review

North Star Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 37,600 shares — an estimated $1.74M sold.

North Star Asset Management first reported a position in ARRY in Q4 2017 and held it in 7 quarters. The position peaked at $1.74M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

North Star Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
North Star Asset Management sold 37,600 Array Biopharma Inc shares in Q3 2019, an estimated $1.74M.
North Star Asset Management first reported a position in Array Biopharma Inc in Q4 2017 and held it in 7 quarters.
North Star Asset Management's Array Biopharma Inc position peaked at $1.74M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on North Star Asset Management's 13F filing for Q3 2019, filed 25 Oct 2019.